Recent publications on Cancer

Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force 2021 May 18;325(19):1978-1998. doi: 10.1001/jama.2021.4417. PubMed

Sung H, Freedman RA, Siegel RL, Hyun N, DeSantis C, Ruddy KJ, Jemal A. Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status. Cancer. 2021 Sep 15;127(18):3310-3324. doi: 10.1002/cncr.33602. Epub 2021 May 18. PubMed

Golmakani MK, Hubbard RA, Miglioretti DL. Non-homogeneous markov chain for estimating the cumulative risk of multiple false positive screening tests. Biometrics. 2021 May 3. doi: 10.1111/biom.13484. [Epub ahead of print]. PubMed

Makhnoon S, Bowen DJ, Shirts BH, Fullerton SM, Larson EB, Ralston JD, Leppig KA, Crosslin DR, Veenstra D, Jarvik GP The FamilyTalk randomized controlled trial: patient-reported outcomes in clinical genetic sequencing for colorectal cancer 2021 May;32(5):483-492. doi: 10.1007/s10552-021-01398-1. Epub 2021-02-16. PubMed

Lewis CC, Hannon PA, Klasnja P, Baldwin LM, Hawkes R, Blackmer J, Johnson A, OPTICC Consortium, represented by Bryan J. Weiner Optimizing Implementation in Cancer Control (OPTICC): protocol for an implementation science center 2021 Apr 23;2(1):44. doi: 10.1186/s43058-021-00117-w. Epub 2021-04-23. PubMed

Inadomi JM, Issaka RB, Green BB What Multi-Level Interventions Do We Need to Increase the Colorectal Cancer Screening Rate to 80%? 2021 Apr;19(4):633-645. doi: 10.1016/j.cgh.2019.12.016. Epub 2019-12-27. PubMed

Malone C, Buist DSM, Tiro J, Barlow W, Gao H, Lin J, Winer RL Out of reach? Correlates of cervical cancer underscreening in women with varying levels of healthcare interactions in a United States integrated delivery system 2021 Apr;145:106410. doi: 10.1016/j.ypmed.2020.106410. Epub 2020-12-31. PubMed

Gould MK, Altman DE, Creekmur B, Qi L, de Bie E, Golden S, Kaplan CP, Kelly K, Miglioretti DL, Mularski RA, Musigdilok VV, Smith-Bindman R, Steltz JP, Wiener RS, Aberle DR, Dyer DS, Vachani A Guidelines for the Evaluation of Pulmonary Nodules Detected Incidentally or by Screening: A Survey of Radiologist Awareness, Agreement, and Adherence From the Watch the Spot Trial 2021 Apr;18(4):545-553. doi: 10.1016/j.jacr.2020.10.003. Epub 2020-11-17. PubMed

Farjah F, Monsell SE, Gould MK, Smith-Bindman R, Banegas MP, Heagerty PJ, Keast EM, Ramaprasan A, Schoen K, Brewer EG, Greenlee RT, Buist DSM Association of the Intensity of Diagnostic Evaluation With Outcomes in Incidentally Detected Lung Nodules 2021 Apr;181(4):480-489. doi: 10.1001/jamainternmed.2020.8250. PubMed

Meenan RT, Baldwin LM, Coronado GD, Schwartz M, Coury J, Petrik AF, West II, Green BB Costs of Two Health Insurance Plan Programs to Mail Fecal Immunochemical Tests to Medicare and Medicaid Plan Members 2021 Apr;24(2):255-265. doi: 10.1089/pop.2020.0041. Epub 2020-06-29. PubMed

Shay LA, Kimbel KJ, Dorsey CN, Jauregui LC, Vernon SW, Kullgren JT, Green BB Patients' Reactions to Being Offered Financial Incentives to Increase Colorectal Screening: A Qualitative Analysis 2021 Mar;35(3):421-429. doi: 10.1177/0890117120987836. Epub 2021-01-28. PubMed

Miglioretti DL, Bissell MCS, Kerlikowske K, Buist DSM, Cummings SR, Henderson LM, Onega T, O'Meara ES, Rauscher GH, Sprague BL, Tosteson ANA, Wernli KJ, Lee JM, Lee CI Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity 2021 Mar;4(3):e211974. doi: 10.1001/jamanetworkopen.2021.1974. Epub 2021-03-01. PubMed

Wernli KJ, Knerr S, Li T, Leppig K, Ehrlich K, Farrell D, Gao H, Bowles EJA, Graham AL, Luta G, Jayasekera J, Mandelblatt JS, Schwartz MD, O'Neill SC Effect of Personalized Breast Cancer Risk Tool on Chemoprevention and Breast Imaging: ENGAGED-2 Trial 2021 Feb;5(1). doi: 10.1093/jncics/pkaa114. Epub 2021-01-14. PubMed

Lee CI, Zhu W, Onega T, Henderson LM, Kerlikowske K, Sprague BL, Rauscher GH, O'Meara ES, Tosteson ANA, Haas JS, diFlorio-Alexander R, Kaplan C, Miglioretti DL Comparative Access to and Use of Digital Breast Tomosynthesis Screening by Women's Race/Ethnicity and Socioeconomic Status 2021 Feb;4(2):e2037546. doi: 10.1001/jamanetworkopen.2020.37546. Epub 2021-02-01. PubMed

Ashare RL, Bernstein SL, Schnoll R, Gross R, Catz SL, Cioe P, Crothers K, Hitsman B, Marhefka SL, McClure JB, Pacek LR, Vidrine DJ, Vilardaga R, Kaufman A, Edelman EJ The United States National Cancer Institute's Coordinated Research Effort on Tobacco Use as a Major Cause of Morbidity and Mortality among People with HIV 2021 Jan 22;23(2):407-410. doi: 10.1093/ntr/ntaa155. PubMed

Coury J, Miech EJ, Styer P, Petrik AF, Coates KE, Green BB, Baldwin LM, Shapiro JA, Coronado GD What's the "secret sauce"? How implementation variation affects the success of colorectal cancer screening outreach 2021 Jan 11;2(1):5. doi: 10.1186/s43058-020-00104-7. Epub 2021-01-11. PubMed

Durham DD, Roberts MC, Khan CP, Abraham LA, Smith RA, Kerlikowske K, Miglioretti DL Age at initiation of screening mammography by family history of breast cancer in the breast cancer surveillance consortium 2021 Jan;32(1):103-107. doi: 10.1007/s10552-020-01354-5. Epub 2020-10-24. PubMed

Kriplani A, Lavery JA, Mishra A, Korenstein D, Lipitz-Snyderman AN, Boudreau DM, Moryl N, Gillespie EF, Salz T Trends in chronic opioid therapy among survivors of head and neck cancer 2021 Jan;43(1):223-228. doi: 10.1002/hed.26478. Epub 2020-09-22. PubMed

Sung H, Hyun N, Leach C, Yabroff R, Jemal A. Patterns of the risk for subsequent primary cancer among survivors of adult-onset cancers in the United States. JAMA. 2020 Dec 22;324(24):2521-2535. doi: 10.1001/jama.2020.23130. PubMed

Wernli KJ, Callaway KA, Henderson LM, Kerlikowske K, Lee JM, Ross-Degnan D, Wallace JK, Wharam JF, Zhang F, Stout NK Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016 2020 Dec 15;126(24):5293-5302. doi: 10.1002/cncr.33140. Epub 2020-09-28. PubMed